VEC

WHO Warns Of Increased Risk Of Vector-borne Diseases In Tsunami-affected Areas

The World Health Organization (WHO) warned about increased risk of vector-borne diseases such as malaria and dengue fever across tsunami-affected areas in Southeast Asia. Nearly four weeks after the disaster struck the region on 26 December, the organization is strengthening its disease surveillance, stagnant water conditions creating conditions for mosquito vectors to multiply to sufficient leve...

The insect vector always bites twice

The reality of the threat from vector-borne diseases has been recognized and the problem is prompting research scientists to take a strong interest. Most of these infections, classified as emerging or re-emerging diseases, are linked to ecosystem changes, climatic variations or pressure from human activities. Malaria, sleeping sickness and so on lead to the death of millions of people in the w...

VEC at Biology Products

pMIR-mU6-Luc, Mouse U6 Luciferase Control Vector from Mirus Bio Corporation

Description:The potential applications for the use of small interfering RNA (siRNA) molecules to silence gene expression via the RNA interference (RNAi) pathway have generated tremendous interest in the cellular and molecular biology fields. siRNA for experimental use can be synthesized in vitro, either chemically or enzymatically, and then transfected into the target cells in vitro or in vivo. A convenient...
Company:Mirus Bio Corporation

pMIR-mU6, Mouse U6Template (Vector) from Mirus Bio Corporation

Description:The potential applications for the use of small interfering RNA (siRNA) molecules to silence gene expression via the RNA interference(RNAi) pathway have generated tremendous interest in the cellular and molecular biology fields. siRNA for experimental use can besynthesized in vitro, either chemically or enzymatically, and then transfected into the target cells in vitro or in vivo [1-4]. A conve...
Company:Mirus Bio Corporation

pMIR-hU6-Luc, Human U6 Luciferase Control Vector from Mirus Bio Corporation

Description:The potential applications for the use of small interfering RNA (siRNA) molecules to silence gene expression via the RNA interference (RNAi) pathway have generated tremendous interest in the cellular and molecular biology fields. siRNA for experimental use can be synthesized in vitro, either chemically or enzymatically, and then transfected into the target cells in vitro or in vivo. A convenient...
Company:Mirus Bio Corporation

LabShare 3.0 for Vector NTI Data Management Software from Invitrogen

Description:LabShare for Vector NTI allows you to store and manage very large amounts of molecular biology data in a secure central relational database. Storing and managing data in this way creates an invaluable resource for clone tracking and enables you to locate your data easily for immediate analysis. LabShare software integrates seamlessly with Invitrogen's desktop sequence analysis applications Vector...
Company:Invitrogen

pYD1 Yeast Display Vector from Invitrogen

Description:The pYD1 Yeast Display Vector is specifically designed to target and display recombinant proteins on the surface of Saccharomyces cerevisiae. Displayed proteins can be analyzed for their ability to interact with known or putative ligands. pYD1 uses the a-agglutinin yeast adhesion receptor which consists of two domains, Aga1 and Aga2, to display recombinant protein on the surface of S. cerevisiae....
Company:Invitrogen

More>>

VEC at Biology Technology

A New C-Terminal GST Vector for Protein Production in S. pombe

Stratagene Stratagene has constructed and tested the new pESP-3 vector, which can beused for C-terminal fusion with glutathione-S-transferase (GST) and for protein production in Schizosaccharomyces pombe....

Generate Adenovirus Vectors in E. coli by Homologous Recombination with the AdEasy Adenoviral Vector System

Efficient gene transfer and high-level protein expression within a varietyof cells Stratagene Recombinant adenoviruses provide a versatile means of gene delivery andexpression. We describe the AdEasy adenoviral vectorsystem, whichsimp...

An Epitope Tagging Vector for Gene Expression in Mammalian Cells

Stratagene The pCMV-Tag1 vector is an epitope tagging vector designed for geneexpression in mammalian cells. A target gene inserted into the pCMV-Tag1 vectorca...

Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in Mammalian Cells

Stratagene mammalian expressionsystem allows tightc...

Epitope-Tagging Vectors for Functional Analysis in Yeast

Stratagene Stratagene has developed a series of epitope-tagging vectors to expressand functionally analyze eukaryotic genes in the budding yeast Saccharomyce...

More>>

VEC at Biology Dictionary

Vector

in a <a...

Vectors

must be capable of self-replicating inside a <a...

Shuttle vector

<a hre...

Expression Vector

e...

Cloning vector

...

VEC at Medicine News

Glivec - New Hope For CMC Patients

For those unlucky to be afflicted by the deadly chronic myeloid leukemia (CMC) and their near and dear ones, there's some good news. One of the deadliest forms of leukemia - commonly called 'blood cancer' - kills thousands across the globe. Chronic myeloid leukemia was one of the deadliest killers around and still continues to be one. But there's good news. Multinational pharmaceut...

GLEEVEC - An Oral treatment for leukemia

The U.S.Food and Drug Administration (FDA) at a conference in Washington, approves the new leukemia drug-GLEEVEC, first of its kind that directly removes the sign of a protein known to cause cancer. It is given as an oral treatment for chronic myelogenous leukemia (CML). Other molecular-targeting drugs previously approved by the FDA interfere with proteins associated with other cancer...

GLEEVEC - An Oral treatment for leukemia

The U.S.Food and Drug Administration (FDA) at a conference in Washington, approves the new leukemia drug-GLEEVEC, first of its kind that directly removes the sign of a protein known to cause cancer. It is given as an oral treatment for chronic myelogenous leukemia (CML). Other molecular-targeting drugs previously approved by the FDA interfere with proteins associated with other cancer...

Gleevec gets hopeful results

The Food and Drug Administration approved the drug, Gleevec, for the treatment of chronic myelogenous leukemia, a form of cancer that affects about 4,500 people in the USA each year. A study supports Gleevec's image as a potential cure for this kind of cancer, which, although cases are rare, can be deadly. // A new study adds to the evidence suggesting that a heavily publicized drug tr...

Gleevec for Lung Disease

Pulmonary fibrosis is a progressive lung disease that, according to the Pulmonary Fibrosis Foundation, claims the lives of 40,000 people every year. There's often not a known cause although// smoking and some occupations are risk factors. Now, a new treatment may give patients what they're looking for -- more time. Michael Dixon is enjoying every minute he has with his wife Debbie. Ea...

More>>

VEC at Medicine Products

Synovectomy Rongeur

Description:...
Company:AESCULAP

Gigli (Olivecrona) Wire Saws

Description:30 cm - 11 3/4, packages 5 pcs....
Company:Medicon eG

VectorVision Cranial

Description:BrainLAB combines ease of use with high software functionality in order to offer an image guided system for neurosurgery that is tailored to the surgeons individual needs. With a 50% usage rate and a user base of more than 500 physicians, VectorVision Cranial is the most frequently employed image-guided system in Neurosurgery....
Company:BrainLAB Inc.

Vectographic Slide 9200

Description:Pediatric: Tumbling "E" Acuity, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Company:Stereo Optical Company

Vectographic Slide 9100

Description:Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Company:Stereo Optical Company

More>>

VEC at Medicine Technology

Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo

Demonstrates Positive Effect on Objective and Subjective SleepMeasures MINNEAPOLIS, June 13, 2007 /PRNewswire-FirstCall/ -- Accordingto study results presented today at SLEEP 2007, the 21st annualmeeting of the Associated Professional Sleep Societies (APSS),VEC-162, a balanced melatonin (MT1/MT2) receptor agonist beingdeveloped by Vanda Pharmaceuticals Inc. , demonstrated improvementsin...

Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the Annual Meeting of the Associated Professional Sleep Societies

ROCKVILLE, Md., June 08, 2007 /PRNewswire-FirstCall/ -- VandaPharmaceuticals Inc. announced today that Dr. Tom Roth, Director ofthe Henry Ford Sleep Disorders and Research Center in Detroit, MI,will deliver an oral presentation on recent Phase III clinicaltrial results for VEC-162, Vanda's balanced melatonin (MT1/MT2)receptor agonist, at SLEEP 2007, the 21st annual meeting of theAssociat...

GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO

GAITHERSBURG, Md.--(BUSINESS WIRE)--Jun 4, 2007 - GenVec, Inc.(Nasdaq: GNVC) announced today that updated preliminary safety andefficacy data from the clinical development program of its leadproduct TNFerade(TM) was presented in a poster session ongastrointestinal cancers at the annual meeting of American Societyfor Clinical Oncology in Chicago, IL by Dr. Mitchell Posner, of theUniversity o...

GenVec Presents Research on New Ad35 Adenovector at ARVO

GAITHERSBURG, Md.--(BUSINESS WIRE)--May 10, 2007 - GenVec, Inc.(Nasdaq:GNVC) today announced pre-clinical research demonstratingthe ability of the Company's new adenovector, Ad35, to induce andsustain protein production in the eye. Lisa L. Wei, Ph.D., GenVec'sDirector of Pre-Clinical Research, presented a poster, AlternateSerotype Adenovector Gives Long-Term Expression in the Eye, at theAss...

Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic Colorectal Cancer Patients Published

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Apr 30, 2007 - Amgen(NASDAQ:AMGN), today announced final results from a pivotal Phase 3trial which showed that Vectibix(TM) (panitumumab), a fully humanmonoclonal antibody directed against the epidermal growth factorreceptor (EGFr), prolonged progression-free survival (PFS) comparedto best supportive care (BSC) in metastatic colorectal cancerpatients...

More>>

VEC at Medicine Definition

Live vector vaccine

...

VEC at Medicine Dictionary

Vector

<a href="/ ?q=/ Medicine-Dictionary/ organ" class="hiv...